Psychiatry Research: Neuroimaging
Volume 164, Issue 3 , Pages 215-222 , 30 December 2008

Neuroanatomical correlates of neurological soft signs in antipsychotic-naive schizophrenia

  • Ganesan Venkatasubramanian

      Affiliations

    • Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore: 5600 29, India
    • Corresponding Author InformationCorresponding author. Department of Psychiatry, National Institute of Mental Health and Neurosciences, Hosur Road, Bangalore: 560029, India. Tel.: +91 80 26995256; fax: +91 80 26564830.
    • ,
  • Peruvumba N. Jayakumar

      Affiliations

    • Department of Neuroimaging and Interventional Radiology, National Institute of Mental Health and Neurosciences, Bangalore: 560029, India
    • ,
  • Bangalore. N. Gangadhar

      Affiliations

    • Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore: 5600 29, India
    • ,
  • Matcheri S. Keshavan

      Affiliations

    • Department of Psychiatry & Behavioral Neurosciences, Wayne State University School of Medicine, Detroit, MI 48201, USA

Received 13 June 2007 ,Revised 28 October 2007 ,Accepted 22 December 2007.

References 

  1. Andreasen NC. A unitary model of schizophrenia: Bleuler's “fragmented phrene” as schizencephaly. Archives of General Psychiatry. 1999;56:781–787
  2. Ashburner J, Friston KJ. Voxel-based morphometry — the methods. Neuroimage. 2000;11(6 Pt 1):805–821
  3. Bersani G, Clemente R, Gherardelli S, Pancheri P. Deficit of executive functions in schizophrenia: relationship to neurological soft signs and psychopathology. Psychopathology. 2004;37:118–123
  4. Bersani G, Paolemili M, Quartini A, Clemente R, Gherardelli S, Iannitelli A, et al. Neurological soft signs and cerebral measurements investigated by means of MRI in schizophrenic patients. Neuroscience Letters. 2007;413(1):82–87
  5. Bottmer C, Bachmann S, Pantel J, Essig M, Amann M, Schad LR, et al. Reduced cerebellar volume and neurological soft signs in first-episode schizophrenia. Psychiatry Research: Neuroimaging. 2005;140:239–250
  6. Brett M, Johnsrude IS, Owen AM. The problem of functional localization in the human brain. Nature Reviews Neuroscience. 2002;3(3):243–249
  7. Buchanan RW, Heinrichs DW. Neurological evaluation scale: a structured instrument for assessment of neurological signs in schizophrenia. Psychiatry Research. 1989;27:335–350
  8. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, et al. Positron emission tomography studies of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biological Psychiatry. 1987;22:479–494
  9. Buchsbaum MS, Potkin S, Siegel B, Lohr J, Katz M, Gottschalk L, et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry. 1992;49:966–974
  10. Buchsbaum MS, Shihabuddin L, Brickman AM, Miozzo R, Prikryl R, Shaw R, et al. Caudate and putamen volumes in good and poor outcome patients with schizophrenia. Schizophrenia Research. 2003;64:53–62
  11. Chua SE, Cheung C, Cheung V, Tsang JT, Chen EY, Wong JC, et al. Cerebral grey, white matter and CSF in never-medicated, first-episode schizophrenia. Schizophrenia Research. 2007;89:12–21
  12. Dazzan P, Morgan KD, Orr KG, Hutchinson G, Chitnis X, Suckling J, et al. The structural brain correlates of neurological soft signs in AESOP first-episode psychoses study. Brain. 2004;127:143–153
  13. Dazzan P, Morgan KD, Chitnis X, Suckling J, Morgan C, Fearon P, et al. The structural brain correlates of neurological soft signs in healthy individuals. Cerebral Cortex. 2006;16:1225–1331
  14. Evans JJ, Chua SE, McKenna PJ, Wilson BA. Assessment of the dysexecutive syndrome in schizophrenia. Psychological Medicine. 1997;27(3):635–646
  15. Ewing JA. Detecting alcoholism. The CAGE questionnaire. JAMA. 1984;252:1905–1907
  16. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV Axis I Disorders: User's Guide. Washington, DC: American Psychiatric Press; 1997;
  17. Flaherty AW, Graybiel AM. Input–output organization of the sensorimotor striatum in the squirrel monkey. Journal of Neuroscience. 1994;14:599–610
  18. Friston K. Disconnection and cognitive dysmetria in schizophrenia. American Journal of Psychiatry. 2005;162:429–432
  19. Fuster JM. The prefrontal cortex — an update: time is of essence. Neuron. 2001;30:319–333
  20. Genovese CR, Lazar NA, Nichols TE. Thresholding of statistical maps in functional neuroimaging using false discovery rate. NeuroImage. 2002;15:772–786
  21. Goldberg DP, Gater R, Sartorius N, Ustun TB, Piccinelli M, Gureje O, et al. The validity of two versions of the GHQ in the WHO study of mental illness in general health care. Psychological Medicine. 1997;7:191–197
  22. Good CD, Johnsrude I, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. A voxel-based morphometric study of ageing in 465 normal adult human brains. NeuroImage. 2001;14:21–36
  23. Gupta S, Andreasen NC, Arndt S, Flaum M, Schultz SK, Hubbard WC, et al. Neurological soft signs in neuroleptic-naive and neuroleptic-treated schizophrenic patients and in normal comparison subjects. American Journal of Psychiatry. 1995;152:191–196
  24. Guy W. Abnormal Involuntary Movements Scale (AIMS). ECDEU Assessment Manual for Pharmacology. Rockville, Md: US Dept. of Health, Education, and Welfare; 1976;
  25. Häfner H, Riecher-Rössler A, Hambrecht M, Maurer K, Meissner S, Schmidtke A, et al. IRAOS: an Instrument for the Retrospective Assessment of the Onset of Schizophrenia. Schizophrenia Research. 1992;6:209–223
  26. Heinrichs DW, Buchanan RW. Significance and meaning of neurological signs in schizophrenia. American Journal of Psychiatry. 1988;145:11–18
  27. Ho BC, Mola C, Andreasen NC. Cerebellar dysfunction in neuroleptics-naive schizophrenia patients: clinical, cognitive, and neuroanatomic correlates of cerebellar neurologic signs. Biological Psychiatry. 2004;55:1146–1153
  28. Hoff AL, Riordan H, O'Donnell DW, Morris L, DeLisi LE. Neuropsychological functioning of first-episode schizophreniform patients. American Journal of Psychiatry. 1992;149:898–903
  29. Jayakumar PN, Venkatasubramanian G, Gangadhar BN, Janakiramaiah N, Keshavan MS. Optimized voxel-based morphometry of gray matter volume in first-episode, antipsychotic-naive schizophrenia. Progress in Neuropsychopharmacology/Biological Psychiatry. 2005;29:587–591
  30. Kay SR, Fizbein A, Opler A. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophrenia Bulletin. 1987;2:261–276
  31. Keshavan MS, Sanders RD, Sweeney JA, Diwadkar VA, Goldstein G, Pettegrew JW, et al. Diagnostic specificity and neuroanatomical validity of neurological abnormalities in first-episode psychoses. American Journal of Psychiatry. 2003;160:1298–1304
  32. Maldjian JA, Laurienti PJ, Burdette JB, Kraft RA. An automated method for neuroanatomic and cytoarchitectonic atlas-based interrogation of fMRI data sets. Neuroimage. 2003;19:1233–1239
  33. Matsumoto N, Hanakawa T, Maki S, Graybiel AM, Kimura M. Role of nigrostriatal dopamine system in learning to perform sequential motor tasks in a predictive manner. Journal of Neurophysiology. 1999;82:978–998
  34. Menon V, Glover GH, Pfefferbaum A. Differential activation of dorsal basal ganglia during externally and self paced sequences of arm movements. Neuroreport. 1998;9:1567–1573
  35. Mittal VA, Hasenkamp W, Sanfilipo M, Wieland S, Angrist B, Rotrosen J, et al. Relation of neurological soft signs to psychiatric symptoms in schizophrenia. Schizophrenia Research. 2007;94:37–44
  36. Picard, H., Amado, I., Mouchet-Mages, S., Olié, J.P., Krebs, M.O., 2008. The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences. Schizophrenia Bulletin 34, 155–172.
  37. Reynolds G, Czudek C, Bzowej N, Seeman P. Dopamine receptor asymmetry in schizophrenia. Lancet. 1987;1:979
  38. Sanders RD, Keshavan MS, Schooler NR. Neurological examination abnormalities in neuroleptic-naive patients with first-break schizophrenia: preliminary results. American Journal of Psychiatry. 1994;151:1231–1233
  39. Sanders RD, Joo YH, Almasy L, Wood J, Keshavan MS, Pogue-Geile MF, et al. Are neurologic examination abnormalities heritable? A preliminary study. Schizophrenia Research. 2006;86:172–180
  40. Schmahmann JD, Sherman JC. The cerebellar cognitive affective syndrome. Brain. 1999;121:561–579
  41. Shihabuddin L, Buchsbaum MS, Hazlett EA, Silverman J, New A, Brickman AM, et al. Striatal size and relative glucose metabolic rate in schizotypal personality disorder and schizophrenia. Archives of General Psychiatry. 2001;58:877–884
  42. Strangman G, Heindel WC, Anderson JA, Sutton JP. Learning motor sequences with and without knowledge of governing rules. Neurorehabilitative Neural Repair. 2005;19:93–114
  43. Talairach J, Tournoux P. A Coplanar Stereotaxic Atlas of a Human Brain. Stuttgart: Thieme; 1988;
  44. Umetsu A, Okuda J, Fujii T, Tsukiura T, Nagasaka T, Yanagawa I, et al. Brain activation during the fist-edge-palm test: a functional MRI study. Neuroimage. 2002;17:385–392
  45. Venkatasubramanian G, Latha V, Gangadhar BN, Janakiramaiah N, Subbakrishna DK, Jayakumar PN, et al. Neurological soft signs in never-treated schizophrenia. Acta Psychiatrica Scandinavica. 2003;108:144–146

PII: S0925-4927(07)00267-3

doi: 10.1016/j.pscychresns.2007.12.021

Psychiatry Research: Neuroimaging
Volume 164, Issue 3 , Pages 215-222 , 30 December 2008

Article Tools

* Image Usage & Resolution